Press Releases

Forward Science prides itself on continuing to innovate the latest technology into cost effective solutions to change more lives. With the launch of its latest innovative product for dentists and periodontists...

Houston, TX (September 2024) – Forward Science is honored to announce that it has been awarded the 2024 Houston Award in the MedTech Company category by the Houston Award Program. This marks the seventh consecutive year that Forward Science has received this accolade...

Forward Science is proud to announce the recipients of the annual Forward Science Gold Awards, recognizing outstanding dedication and commitment to oral cancer screening using OralID. This prestigious award celebrates one doctor and one...

In 2024, more than 2 million new cancer cases are expected to be diagnosed in the US. Despite advancements in technology and increased awareness, oral cancer remains an outlier, as survival rates have not increased for over three decades.

Houston, TX (February 2024) – Since Forward Science's FDA Clearance of SalivaMAX on December 23, 2015, the company has consistently demonstrated the product's effectiveness through multiple clinical studies.

Houston, TX (January 2024) – Forward Science’s flagship device, OralID®, has once again been recognized as “Top Oral Cancer Screening Device” by Dental Advisor, marking a decade straight of this recognition.

Over the past 10 years, Forward Science has evolved into a pioneering MedTech company that has revolutionized oral health through its commitment to cutting-edge products and unwavering dedication to excellence.

Houston, TX (November 2023) - DECA Dental Group announced today that they are partnering with Forward Science to utilize OralID to strengthen their oral cancer...

Forward Science, a vertically integrated MedTech company based in Houston, Texas, was founded in 2012 with the mission to change lives through innovative, costeffective products.